Absci (ABSI) Competitors $2.76 +0.07 (+2.42%) Closing price 07/3/2025 03:57 PM EasternExtended Trading$2.77 +0.02 (+0.69%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ABSI vs. VVX, UPBD, OLO, CRTO, ASTH, FLYW, STGW, RDWR, ETWO, and EVHShould you be buying Absci stock or one of its competitors? The main competitors of Absci include V2X (VVX), Upbound Group (UPBD), OLO (OLO), Criteo (CRTO), Astrana Health (ASTH), Flywire (FLYW), Stagwell (STGW), Radware (RDWR), E2open Parent (ETWO), and Evolent Health (EVH). These companies are all part of the "business services" industry. Absci vs. Its Competitors V2X Upbound Group OLO Criteo Astrana Health Flywire Stagwell Radware E2open Parent Evolent Health V2X (NYSE:VVX) and Absci (NASDAQ:ABSI) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings, media sentiment and analyst recommendations. Do analysts prefer VVX or ABSI? V2X currently has a consensus price target of $62.80, suggesting a potential upside of 27.22%. Absci has a consensus price target of $8.40, suggesting a potential upside of 204.90%. Given Absci's stronger consensus rating and higher probable upside, analysts clearly believe Absci is more favorable than V2X.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score V2X 2 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.64Absci 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation and earnings, VVX or ABSI? V2X has higher revenue and earnings than Absci. Absci is trading at a lower price-to-earnings ratio than V2X, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioV2X$4.32B0.36$34.68M$1.2938.27Absci$4.53M77.58-$103.11M-$0.92-2.99 Does the media refer more to VVX or ABSI? In the previous week, V2X and V2X both had 4 articles in the media. Absci's average media sentiment score of 0.60 beat V2X's score of 0.39 indicating that Absci is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment V2X 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Absci 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of VVX or ABSI? 95.2% of V2X shares are owned by institutional investors. Comparatively, 52.1% of Absci shares are owned by institutional investors. 0.9% of V2X shares are owned by company insiders. Comparatively, 10.5% of Absci shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, VVX or ABSI? V2X has a beta of 0.24, indicating that its stock price is 76% less volatile than the S&P 500. Comparatively, Absci has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500. Is VVX or ABSI more profitable? V2X has a net margin of 0.96% compared to Absci's net margin of -2,232.13%. V2X's return on equity of 13.97% beat Absci's return on equity.Company Net Margins Return on Equity Return on Assets V2X0.96% 13.97% 4.49% Absci -2,232.13%-53.69%-45.89% SummaryV2X beats Absci on 10 of the 16 factors compared between the two stocks. Get Absci News Delivered to You Automatically Sign up to receive the latest news and ratings for ABSI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ABSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABSI vs. The Competition Export to ExcelMetricAbsciMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$353.34M$2.92B$5.56B$9.05BDividend YieldN/A2.44%5.24%3.99%P/E Ratio-2.998.2819.9620.26Price / Sales77.58283.26419.56119.26Price / CashN/A41.7026.2128.59Price / Book1.777.538.035.65Net Income-$103.11M-$55.14M$3.18B$249.15M7 Day Performance5.15%4.61%2.93%3.28%1 Month Performance-9.08%0.90%1.72%3.95%1 Year Performance-13.09%5.40%34.39%20.98% Absci Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABSIAbsci2.0692 of 5 stars$2.76+2.4%$8.40+204.9%-13.1%$353.34M$4.53M-2.99210News CoverageAnalyst ForecastGap UpVVXV2X3.9875 of 5 stars$45.75+2.2%$63.67+39.2%+4.1%$1.42B$4.32B35.4716,100UPBDUpbound Group4.5557 of 5 stars$23.92-1.2%$34.50+44.2%-9.7%$1.40B$4.32B5.9911,970Positive NewsOLOOLO1.4686 of 5 stars$8.52+1.9%$9.00+5.7%+135.9%$1.39B$299.11M425.96710Trending NewsAnalyst DowngradeOptions VolumeGap UpCRTOCriteo4.1872 of 5 stars$23.68+0.3%$46.70+97.2%-37.6%$1.37B$1.93B9.633,507News CoverageGap UpASTHAstrana Health3.3149 of 5 stars$25.07+4.5%$53.29+112.5%-36.4%$1.35B$2.03B34.821,900News CoverageAnalyst RevisionFLYWFlywire4.3103 of 5 stars$11.02+1.6%$15.00+36.1%-26.2%$1.32B$492.14M108.501,250STGWStagwell2.5239 of 5 stars$4.43-0.4%$8.60+94.1%-33.4%$1.19B$2.84B9.8914,607RDWRRadware2.8117 of 5 stars$28.25+2.8%$27.00-4.4%+59.0%$1.17B$274.88M104.631,208ETWOE2open Parent1.0753 of 5 stars$3.24+0.5%$2.78-14.2%-29.0%$1.11B$607.69M-1.513,873News CoverageUpcoming EarningsHigh Trading VolumeEVHEvolent Health1.7229 of 5 stars$10.52+13.7%$17.79+69.1%-41.0%$1.09B$2.55B-8.554,500News CoverageHigh Trading Volume Related Companies and Tools Related Companies V2X Competitors Upbound Group Competitors OLO Competitors Criteo Competitors Astrana Health Competitors Flywire Competitors Stagwell Competitors Radware Competitors E2open Parent Competitors Evolent Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABSI) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredGold buying hits 4-year highThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Absci Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Absci With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABSI Stock Alerts